Chiasma, Inc. (CHMA) Announces Additional 44% Workforce Reduction
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Powerful quake hits Panama, damages homes; canal operations normal
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- CoreWeave stock drops on dilution fears and debt concerns
Chiasma Announces Workforce Reduction
August 16, 2016 9:02 AM EDTWALTHAM, Mass., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today announced that it is further reducing its workforce by approximately 44%, primarily in the companys research and general and administrative functions, to lower its operating expenses and extend its cash runway. Â This action follows Chiasmas announcement of a corporate restructuring plan in June 2016, which included an initial workforce reduction composed primarily of the companys commercial personnel. Â Chiasma intends to focus its resources on the continued... More



